Fenoldopam
Fenoldopam is a dopamine D1 receptor agonist, primarily used as a vasodilator in the treatment of hypertension. It functions by activating dopamine receptors in the kidneys, resulting in vasodilation and increased renal blood flow, which can lead to a reduction in blood pressure.
Lab products found in correlation
3 protocols using fenoldopam
Uroguanylin and Fenoldopam Infusion
Pharmacological Compounds for Cell Experiments
Dopamine Agonists and Osteoblast Function
To study the effect of dopamine on activated osteoblasts, cells were cultured following the mineralization protocols described above. After 3 weeks, cells were treated with dopamine agonists in fresh medium for further 24 h. Afterwards, supernatants were collected and frozen in aliquots at −80 °C until analysis.
The concentrations chosen for Fenoldopam and Ropinirole were around the concentration described to have the best binding affinity, ±5–10× and had no toxic effects on the cells.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!